DNA Test Kits Market Report 2026

The dna test kits market size has grown rapidly in recent years. It will grow from $2.49 billion in 2025 to $2.98 billion in 2026 at a compound annual growth rate (CAGR) of 19.7%. The growth in the historic period can be attributed to consumer interest in ancestry, early genetic screening services, e-commerce growth, declining testing costs, increased health awareness.

The dna test kits market size is expected to see rapid growth in the next few years. It will grow to $5.52 billion in 2030 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to personalized wellness adoption, digital health platforms, regulatory clarity for consumer tests, preventive healthcare focus, data-driven lifestyle management. Major trends in the forecast period include growing popularity of direct-to-consumer genetic testing, increased demand for ancestry and health risk kits, expansion of home-based sample collection, rising consumer awareness of genetic health, integration of digital platforms for result interpretation.

The rising prevalence of genetic disorders is expected to drive the growth of the DNA test kits market in the coming years. Genetic disorders are health conditions caused by abnormalities in the genome, which may result from mutations in single genes (monogenic), multiple genes (polygenic), or chromosomal irregularities. The incidence of genetic disorders is increasing due to greater awareness, improved diagnostic methods, lifestyle changes, and environmental factors that contribute to mutations. DNA test kits support this trend by detecting specific gene mutations or variations linked to inherited conditions, aiding in diagnosis and enabling personalized treatment approaches. For example, in April 2024, the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, reported that approximately one in 700 babies, or about 6,000 newborns, are affected by Down syndrome annually. Additionally, in February 2023, the World Health Organization (WHO), a Switzerland-based specialized UN agency for public health, estimated that congenital diseases cause around 240,000 infant deaths globally within the first 28 days of life each year. Therefore, the increasing prevalence of genetic disorders is fueling the growth of the DNA test kits market.

Companies operating in the DNA test kits market are increasingly focused on developing innovative products, such as personalized DNA kits, to gain a competitive advantage. Personalized DNA kits analyze an individual’s DNA to provide tailored insights into health, ancestry, and personal traits. For instance, in April 2023, MapMyGenome, an India-based genomics company, launched BeautyMap, India’s first DNA-based test kit offering personalized recommendations for skin and hair care products based on a person’s unique genetic profile. The test also includes a free consultation with a certified genetic counselor to help individuals interpret the results and make informed decisions about their customized beauty regimen.

In January 2023, QIAGEN N.V., a Germany-based biotechnology company, acquired Verogen Inc. for $150 million. This acquisition enables QIAGEN to provide a comprehensive workflow for human identification and forensic applications, enhancing its ability to support investigators and researchers in advancing forensic science and accurately identifying suspects. Verogen Inc. is a US-based biotechnology company specializing in DNA test kits for forensic and human identification purposes.

Major companies operating in the dna test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., NeoGenomics Laboratories Inc., Ancestry.com LLC, 23andMe Holding Co, Ambry Genetics Corporation, MyHeritage Ltd., CENTOGENE N.V., Everlywell Inc., Gene by Gene Ltd., Zymo Research Corporation, Devyser, Living DNA Ltd, Veritas Genetics, Nebula Genomics.

North America was the largest region in the DNA test kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dna test kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dna test kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the DNA test kits market by raising costs of imported collection kits, reagents, and laboratory processing components. Consumer-focused markets in North America and Europe are most affected, while emerging regions face affordability challenges. These tariffs increase kit prices by elevating manufacturing, packaging, and laboratory processing expenses, reducing accessibility for direct-to-consumer and preventive genetic testing in price-sensitive segments. However, they also support domestic kit manufacturing and local laboratory partnerships, encouraging regional sourcing of consumables, localized assembly of test kits, and closer collaboration between testing companies and in-country diagnostic labs to stabilize long-term supply and pricing.

The dna test kits market research report is one of a series of new reports that provides dna test kits market statistics, including dna test kits industry global market size, regional shares, competitors with a dna test kits market share, detailed dna test kits market segments, market trends and opportunities, and any further data you may need to thrive in the dna test kits industry. This dna test kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

DNA (deoxyribonucleic acid) test kits are sets containing materials and instructions for collecting an individual’s DNA sample, typically through saliva or cheek swabs. These kits facilitate genetic testing for ancestry, health traits, and susceptibility to certain diseases, with collected samples usually sent to laboratories for analysis, offering personalized insights into a person’s genetic profile.

The main sample types for DNA test kits include saliva, blood, tissue, teeth and bones, hair, and others. Saliva is a fluid produced by the salivary glands in the mouth, containing water, proteins, salts, and sometimes a starch-digesting enzyme. These kits are used in applications such as ancestry testing, diet and nutrition analysis, disease risk assessment, and others, by various end users including hospitals, diagnostic and forensic laboratories, academic and research institutions, and more.

The DNA test kits market consists of sales of DNA collection swabs, saliva collection tubes, transport tubes or containers, DNA sequencers, and DNA extraction and purification kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.